Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

Targeted Therapy (246)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Navitoclax	BCL-2 Inhibitor	Hematologic
Molecule Navitoclax Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism BCL-2 Inhibitor
Obatoclax	BCL-2 Inhibitor	Hematologic
Molecule Obatoclax Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism BCL-2 Inhibitor
Lisaftoclax	BCL-2 Inhibitor	Hematologic
Molecule Lisaftoclax Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism BCL-2 Inhibitor
Sonrotoclax	BCL-2 Inhibitor	Hematologic
Molecule Sonrotoclax Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism BCL-2 Inhibitor
APG-2575 (Lisaftoclax)	BCL-2 Inhibitor	Hematologic
Molecule APG-2575 (Lisaftoclax) Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism BCL-2 Inhibitor
Selinexor	XPO1 (Exportin-1) Inhibitor	Hematologic (Multiple Myeloma/DLBCL)
Molecule Selinexor Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma/DLBCL) Drug Class / Mechanism XPO1 (Exportin-1) Inhibitor
Eltanexor	XPO1 (Exportin-1) Inhibitor	Hematologic (Multiple Myeloma/DLBCL)
Molecule Eltanexor Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma/DLBCL) Drug Class / Mechanism XPO1 (Exportin-1) Inhibitor
Idasanutlin	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Idasanutlin Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Navtemadlin	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Navtemadlin Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Brigimadlin	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Brigimadlin Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Siremadlin	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Siremadlin Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Milademetan	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Milademetan Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor

Navitoclax Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism BCL-2 Inhibitor
Obatoclax Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism BCL-2 Inhibitor
Lisaftoclax Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism BCL-2 Inhibitor
Sonrotoclax Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism BCL-2 Inhibitor
APG-2575 (Lisaftoclax) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism BCL-2 Inhibitor
Selinexor Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma/DLBCL) Drug Class / Mechanism XPO1 (Exportin-1) Inhibitor
Eltanexor Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma/DLBCL) Drug Class / Mechanism XPO1 (Exportin-1) Inhibitor
Idasanutlin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Navtemadlin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Brigimadlin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Siremadlin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Milademetan Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor

‹ 1 … 16 17 18 19 20 21 ›

Product Range

Company

Global Network

Products

Navitoclax

Obatoclax

Lisaftoclax

Sonrotoclax

APG-2575 (Lisaftoclax)

Selinexor

Eltanexor

Idasanutlin

Navtemadlin

Brigimadlin

Siremadlin

Milademetan